Cooper Companies (The)
COO · NASDAQ · Health Care
+$0.37 today
- Mkt cap $13.24B
- P/E 57.5
- Day $66.41 – $68.18
Confidence
High conviction
The read
Cooper Companies beats Q2 EPS estimates by 10%, shares rise 8.6%
Cooper Companies reported Q2 EPS of $1.21 versus $1.10 estimate, a 10% beat, driving an 8.6% stock price increase. Institutional ownership remains strong at 106%, with mixed growth metrics and solid valuation signals. Investors should monitor next quarter's EPS growth and margin trends for confirmation of sustainable improvement.
Confidence note: High confidence due to confirmed EPS beat, strong price reaction, and detailed fundamental metrics; limited by absence of explicit guidance.
What happened
Earnings print
Guidance
Price reaction
Street narrative
So what
What changed
What the market is pricing
Fundamental takeaway
Next 30–90 days
Sustained EPS growth above 8% and margin expansion drive multiple re-rating and share price appreciation.
- boltNext quarter EPS growth exceeds 8.4% forecast
- boltOperating margin improves beyond 11.8%
EPS growth remains near forecast with stable margins, supporting current valuation and moderate upside.
- boltEPS growth in line with 8.4% next year forecast
- boltMargins stable around 11-12%
EPS growth disappoints and margins contract, leading to valuation multiple compression and share price decline.
- boltNext quarter EPS growth below 5%
- boltOperating margin falls below 10%
What to do
If you hold it
If you're watching
Keep on your radar
- Next quarter EPS growth rate (due Q3 2026)
- Operating margin trends in upcoming earnings
- Institutional ownership changes over next 3 months
- Stock price relative to 50-day and 200-day moving averages